InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
8
T+90 hit rate
100%
T+90 mean return
+27.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Cohen Raymond W, Chairman & CEO. Officer active across 5 companies, notably Axonics, Inc.. Aggregated, 20 reports have been published. Split: 2 buys · 8 sells. Total volume traded: €13.3m. History available since 10 May 2021. The latest transaction was disclosed on 26 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cohen Raymond W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
30,864 sharesCommon StockSEC:0001193125-26-275834:0
10,000 shares@ US$19.98100.0% of flowCommon SharesSEC:0001193125-26-132324:0
Canonical exit: 24 Jun 2026 (T+90)
44,030 shares0Common StockSEC:0001493152-26-002663:0
17,000 shares@ US$17.0060.8% of flowCommon SharesSEC:0000950170-25-113631:0
Canonical exit: 5 Jun 2025 (T+90)
35,668 shares0Common StockSEC:0000950170-25-102098:0
12,994 sharesCommon SharesSEC:0000950170-25-098339:0
292,731 shares@ US$71.0049.5% of flowCommon StockSEC:0001562180-24-007702:0
25,771 shares@ US$14.190.8% of flowCommon StockSEC:0001562180-24-005843:0
63,400 shares0Common StockSEC:0001562180-24-001009:0
20,750 shares0Common StockSEC:0001562180-23-000873:0
18,684 shares@ US$65.54092.8% of flowCommon StockSEC:0001562180-23-000495:0
18,100 shares@ US$69.49763.1% of flowCommon StockSEC:0001562180-22-006035:0
50,000 shares@ US$60.0015.5% of flowCommon StockSEC:0001562180-22-003045:0
17,787 shares@ US$50.41844.7% of flowCommon StockSEC:0001562180-22-002687:0
43,297 shares0Common StockSEC:0001562180-22-001104:0
50,000 shares@ US$77.1079.9% of flowCommon StockSEC:0001562180-21-005938:0
5,000 sharesCommon StockSEC:0001437749-21-016942:0
33,333 shares@ US$60.005.0% of flowCommon StockSEC:0001562180-21-004197:0
32,833 shares@ US$55.004.5% of flowCommon StockSEC:0001562180-21-003684:0
13,109 shares@ US$52.98161.7% of flowCommon StockSEC:0001562180-21-003441:0
20 of 20 declarations
About Cohen Raymond W
COHEN RAYMOND W is Président-Directeur Général and also serves as Chief Executive Officer at Axonics, Inc., as well as Director at KESTRA MEDICAL TECHNOLOGIES, LTD., RxSight, Inc., InspireMD, Inc. and Biolife Solutions INC. He has 20 filings in total, and across the recent filings available, the transactions are mainly sales, with 440706 EUR of purchases and 32576237 EUR of sales between 2021-05-12 and 2026-06-18.
